H-KKLLTQHFVQENYLEY-OH

Rif. 3D-PP43465

Informazioni sul prodotto

• Nome: H-KKLLTQHFVQENYLEY-OH
• Sinonimi: NH2-Lys-Lys-Leu-Leu-Thr-Gln-His-Phe-Val-Gln-Glu-Asn-Tyr-Leu-Glu-Tyr-OH

Descrizione

Peptide H-KKLLTQHFVQENYLEY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KKLLTQHFVQENYLEY-OH include the following: A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3. DP4-peptide-pulsed dendritic cells Y Zhang , N Renkvist, Z Sun - European journal of , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200425847 Isolation and characterization of an HLA-DPB1* 04: 01-restricted MAGE-A3 T-cell receptor for cancer immunotherapy X Yao, YC Lu , LL Parker, YF Li, M El-Gamil - Journal of , 2016 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2016/06000/isolation_and_characterization_of_an.1.aspx TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets T Straetemans, M Van Brakel - Journal of , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2012/586314 Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE RA Eakins, A Chobrutskiy, JK Teer, DN Patel - Molecular , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589022003893 Messenger RNA-Electroporated Dendritic P van der Bruggen , K Thielemans , KB Michiels - J Immunol, 2004 - academia.eduhttps://www.academia.edu/download/44445104/Messenger_RNA-electroporated_dendritic_c20160405-21306-wguvj4.pdf Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation K Birkholz, M Schwenkert, C Kellner - Blood, The Journal , 2010 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/116/13/2277/27558 Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy ES Schultz, B Schuler-Thurner, V Stroobant - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/2/1304/71731 MAGE-A antigens as targets for cancer immunotherapy E Schooten, A Di Maggio, PMPB en Henegouwen - Cancer treatment , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737218300537 Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial B Escudier, T Dorval, N Chaput , F Andre - Journal of translational , 2005 - Springerhttps://link.springer.com/article/10.1186/1479-5876-3-10 Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules A Bonehill, C Heirman, S Tuyaerts - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/11/6649/80974 Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients A Bonehill, AMT Van Nuffel , J Corthals, S Tuyaerts - Clinical Cancer , 2009 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/15/10/3366/73489 The Melanoma-Associated Antigen Family A (MAGE-A): A promising target for cancer immunotherapy? A Alsalloum, JA Shevchenko, S Sennikov - Cancers, 2023 - mdpi.comhttps://www.mdpi.com/2072-6694/15/6/1779

• Marchio: Biosynth